NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

NWBO has a history of missing deadlines. The most recent major example is when NWBO resized this Phase 3 trial and delayed its completion by a year. While that delay was with more notice than one month out it still came out of left field (though with the benefit of hindsight one could see that Ms. Powers had been laying the groundwork in some public statements).

What about this time?

Well the good news is that the recent regulatory filing mentioned that expenses for the Phase 3 were diminishing of the Phase 3 wound down.

The bad news is that the recent regulatory filing did not (to the best of my recollection) reference the Phase 3 trial completion date of September 2016 even though that would have helped explain more about the draw down in trial expenses and would have reassured shareholders. The bad news is that omission implies that the trial might not be ending in September 2016 and that would be consistent with the fact that this long screening halt has prevented NWBO from fully enrolling the trial.

The shorts are just protecting their investment because they think they can drive NWBO into bankruptcy. If they did gain have huge benefits from shorting from $6.00 to $10.00 then shorting at this level to ride this kill to the ground makes sense since trying to unload would temporarily inflate NWBO's price and while not triggering a short squeeze it would cut into their profits.